Curebound, a philanthropic organization that funds groundbreaking cancer research, announces significant updates for its grant recipients. The 2021 recipient...

Bristol Myers Squibb has announced the acceptance by the U.S. Food and Drug Administration (FDA) of its application for...

The 7th Annual Digital Biomarkers in Clinical Trials conference featured a compelling presentation by Tilo Hache, Director of Strategy...

QuantHealth, a pioneering AI-powered clinical trial design company, has reached a milestone with over 100 successful simulated trials. This...

EMulate Therapeutics’ manuscript, “Magnetic Field Emulations of Small Inhibitor RNA: Effects on GL261 Tumors,” has been accepted for publication...

The discovery of IGC-1A’s potential as a GLP-1 agonist, resulting from IGC Pharma’s advanced Artificial Intelligence (AI) modeling, has...

In this interview, we speak with Carter Keller, CEO at GigaGen, about their innovative recombinant polyclonal antibody therapy, GIGA-2339,...

Walgreens and the Biomedical Advanced Research and Development Authority (BARDA) have joined forces to enhance decentralized clinical trials through...

The European Medicines Agency (EMA) has validated an application to expand the indication of Breyanzi for treating relapsed or...

Ensuring privacy compliance in clinical trials is crucial for protecting participants’ personal data. The regulatory frameworks in the United...